All individuals in LOINC
Label | Id | Description |
---|---|---|
10-20 each day | LA16950-0 | |
10-25 feet | LA170-3 | |
10-Digit Extent of Disease, 1988 (1988+) | LA9125-1 | |
10-Hydroxycarbazepine | MTHU027341 | |
10-Hydroxycarbazepine | LP28716-6 | |
10-Hydroxycarbazepine | Blood | Drug toxicology | LP390811-0 | |
10-Hydroxycarbazepine | Serum or Plasma | Drug toxicology | LP390812-8 | |
10-Hydroxycarbazepine trough [Mass/Vol] | 74961-4 | |
10-Hydroxycarbazepine|MCnc|Pt|ANYBldSerPl | LG12240-4 | |
10-Hydroxycarbazepine|Pt|Ser/Plas | LG41870-3 | |
10-Hydroxycarbazepine/Creatinine | MTHU057788 | |
10-Hydroxycarbazepine/Creatinine | LP284654-3 | |
10-Hydroxycarbazepine/Creatinine | Urine | Drug toxicology | LP390813-6 | |
10-Hydroxycarbazepine/Creatinine:MRto:Pt:Urine:Qn:Confirm | 87766-2 | |
10-Hydroxycarbazepine:MCnc:Pt:Bld:Qn | 60035-3 | |
10-Hydroxycarbazepine:MCnc:Pt:Ser/Plas:Qn | 31019-3 | |
10-Hydroxycarbazepine:SCnc:Pt:Ser/Plas:Qn | 48348-7 | |
10-Hydroxycarbazepine^trough | LP307793-2 | |
10.5 hours post XXX challenge | LP35523-7 | |
10.75 hours post XXX challenge | LP35516-1 |